OK, so WHY the takedown today?? Was is:
-someone found something out with respect to the trial data?
-just a continuation of the flushing out of folks who are saying, enough
of the losses ? Or
-a takedown by those taking advantage of a weak chart, to get cheap shares
in anticipation of the trial data expected by the end of the month?
Hard to believe they will screw up their trial for the 3rd time, so going with the
someone wanted cheap shares. Now I don't expect their development to compete
on an equal basis with a urinalysis test. But do expect it will do what they way its
capable of (detect some drugs, used RECENTLY vs a urinalysis test). And for some?
That will be good enough.
So as a disclaimer: added shares just now. With a market cap of just $6.2 Million or so
at the moment? Easy to see them getting a market cap of say $15-20 Million IF approved
by the fda... 3x the current share price..
Market Data 
Markets 
AI
